FlexNovo: Structure-based searching in large fragment spaces

被引:51
作者
Degen, Joerg
Rarey, Matthias
机构
[1] Center for Bioinformatics (ZBH), University of Hamburg, 20146 Hamburg
关键词
Chemical fragment spaces; Computer chemistry; De novo design; Drug design; Protein-ligand interactions;
D O I
10.1002/cmdc.200500102
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We present a new molecular design program, FLExNovo, for structure-based searching within large fragment spaces following a sequential growth strategy. The fragment spaces consist of several thousands of chemical fragments and a corresponding set of rules that specify how the fragments can be connected. FLExNovo is based on the FLEXX molecular docking software and makes use of its incremental construction algorithm and the underlying chemical models. Interaction energies are calculated by using standard scoring functions. Several placement geometry, physicochemical property (drug-likeness), and diversity filter criteria are directly integrated into the "build-up" process. FLExNovo has been used to design potential inhibitors for four targets of, pharmaceutical interest (dihydrofolate reductase, cyclin-depend- ant kinase 2 cyclooxygenase-2 and the estrogen receptor). We 1 have carried out calculations using different diversity parameters for each of these targets and generated solution sets containing up to 50 molecules. The compounds obtained show that FLEXNovo is able to generate a diverse set of reasonable molecules with drug-like properties. The results, including an automated similarity analysis with the Feature Tree program, indicate that 1 FLExNovo often reproduces structural motifs as well as the corresponding binding modes seen in known active structures.
引用
收藏
页码:854 / 868
页数:15
相关论文
共 72 条
[1]   Predicting synthetic accessibility: Application in drug discovery and development [J].
Baber, JC ;
Feher, M .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (06) :681-692
[2]   Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds [J].
Baurin, N ;
Baker, R ;
Richardson, C ;
Chen, I ;
Foloppe, N ;
Potter, A ;
Jordan, A ;
Roughley, S ;
Parratt, M ;
Greaney, P ;
Morley, D ;
Hubbard, RE .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (02) :643-651
[3]   Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets [J].
Baurin, N ;
Aboul-Ela, F ;
Barril, X ;
Davis, B ;
Drysdale, M ;
Dymock, B ;
Finch, H ;
Fromont, C ;
Richardson, C ;
Simmonite, H ;
Hubbard, RE .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2004, 44 (06) :2157-2166
[4]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[5]   Properties of known drugs. 2. Side chains [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (25) :5095-5099
[6]  
BODA K, 2006, J MED CHEM
[7]  
Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.3.CO
[8]  
2-D
[9]   Site-directed structure generation by fragment-joining [J].
Bohm, HJ .
PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 1995, 3 :21-33
[10]  
BOHM HJ, 1992, J COMPUT AID MOL DES, V6, P61, DOI 10.1007/bf00124387